Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium)
Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium)
Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium)
Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium)
Draft SOO: Task Order

Draft SOO: Onshoring the Manufacturing of
Viral Hemorrhagic Fever Vaccine Candidates

The BioMaP-Consortium has released a Draft Statement of Objectives (SOO) for public feedback to support a new initiative to onshore manufacturing of viral hemorrhagic fever vaccine candidates, including Marburg and Ebola Sudan. The effort aims to transfer production of novel VSV Delta G-based vaccines to U.S. manufacturers, strengthening domestic preparedness and supply chain resilience. Your input will help shape U.S. Government planning.

Feedback Due: Aug. 15, 2025 at 11:59 p.m. ET

Stay tuned for details on the virtual Industry Day!
Learn More
Market Research

Market Research Survey:
Personal Protective Equipment Manufacturing

The BioMaP-Consortium is currently conducting market research for ASPR's Center for Industrial Base Management and Supply Chain to better understand current U.S. manufacturing capabilities for personal protective equipment. If your organization currently manufactures or plans to manufacture any of the following within the next year, we would appreciate your input: man-made fibers, man-made fabrics, nitrile gloves, N95 respirators or masks, or nitrile butadiene rubber. Survey results will be shared with IBMSC to support future planning efforts.

Responses Due: Aug. 19, 2025 at 11:59 p.m. ET
Learn More
AI Webinar

AI Advances & FDA Insights in
Pharmaceutical Manufacturing Webinar

Gain insights from three leaders driving innovation at the intersection of AI and pharmaceutical manufacturing. This webinar will cover cutting-edge technologies and innovations, real-world applications of AI in pharmaceutical manufacturing, key FDA insights, and partnership and collaboration opportunities.

When: Sept. 10, 2025 from 1 to 2 p.m. ET
Sign Up Here
Slide 1

Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium)

Strengthening and enhancing domestic
biopharmaceutical manufacturing capabilities
Learn More
previous arrow
next arrow

Get involved!

Seeking partnerships to rapidly respond to future Public Health Emergencies (PHE)

Member Benefits:

No Cost Barrier for Entry

Pre-negotiated Terms

Fast & Flexible Partnerships

Networking & Engagement with Industry

Industrial Base Expansion of Supply Chain

Engage with the network of organizations and personnel that provide all goods and services in support of the entire biomanufacturing process, to include, but not limited to, raw materials, consumables, and fill-finish services.

Biomanufacturing Capacity Expansion and Reservation

Prepare and provide timely, integrated, and sufficient medical countermeasures in response to emerging pathogens with pandemic potential through establishing, expanding and/or reserving drug substance and/or drug product manufacturing capacities.

Advanced Biomanufacturing Technologies

Address new and emerging technologies, that enhance existing capabilities that increase the speed, quality, safety, yield, efficiency of the biomanufacturing process or the safety, quality, effectiveness, or availability of the resulting biopharmaceutical drug product.